Amyl Therapeutics

{
  "events": [
    {
      "kind": "warrant_issuance",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": "nominal",
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": "nominal",
        "share_class": "ordinaire",
        "n_new_shares": 405110,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Herstal",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-12-22",
    "filing_date": "2025-12-18",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-12-18",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "3R, LEBOUTTE \u0026 CO",
    "ibr_number": null,
    "mission_type": "quasi_apport",
    "individual_name": "Samuel RAHIER"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Neonotaires",
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 405110,
      "class_name": "Ordinaire",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": null,
      "delta_eur": -6152358.0,
      "before_eur": null,
      "decrease_purpose": "loss_absorption",
      "contribution_type": "reserves_incorporation",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "LIEGEGreffe",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-02-04",
    "filing_date": "2025-01-23",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_speciale",
    "act_date": "2025-01-23",
    "unanimous": true,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2024-12-23"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "Amyl Therapeutics",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0848.685.167",
    "org_name": "FINANCIAL WAY SRL",
    "person_name": "Christophe Mathieu",
    "org_rep_person_name": "Christophe Mathieu",
    "person_role_at_subject": "administrateur"
  },
  "co_filed_documents": [],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "stage": null,
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-02-04",
    "filing_date": "2025-01-23",
    "act_kind_objet": "R\u00E9duction des apports disponibles"
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2024-12-23",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "conversion_legal_form",
  "report_waiver": null,
  "restructuring": null,
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "Amyl Therapeutics",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0848.685.167",
    "org_name": "FINANCIAL WAY SRL",
    "person_name": "Christophe Mathieu",
    "org_rep_person_name": "Christophe Mathieu"
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale sp\u00E9ciale d\u0027Amyl Therapeutics a d\u00E9cid\u00E9, \u00E0 l\u0027unanimit\u00E9, de r\u00E9duire les apports disponibles en compensant les pertes de 2023 et en constituant une r\u00E9serve pour couvrir le solde des pertes de 2024. L\u0027assembl\u00E9e a \u00E9galement donn\u00E9 procuration \u00E0 FINANCIAL WAY SRL pour \u00E9mettre, ex\u00E9cuter et signer tous les documents n\u00E9cessaires \u00E0 l\u0027ex\u00E9cution de ces d\u00E9cisions, y compris la publication au Moniteur belge.",
  "co_filed_documents": [],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Li\u00E8ge",
        "region": null,
        "street": "Boulevard Patience et Beaujonc",
        "country": "BE",
        "postcode": "4000",
        "box_number": null,
        "street_number": "3"
      },
      "old_address": {
        "city": "Seraing",
        "region": null,
        "street": "Rue d\u00E8l Rodge Cinse",
        "country": "BE",
        "postcode": "4102",
        "box_number": null,
        "street_number": "98"
      },
      "effective_date": "2024-03-12",
      "evidence_quote": "Le conseil d\u0027administration d\u00E9cide de transf\u00E9rer le si\u00E8ge de la soci\u00E9t\u00E9 de la Rue d\u00E8l Rodge Cinse 98 \u00E0 4102 Seraing vers le Boulevard Patience et Beaujonc 3 \u00E0 4000 Li\u00E8ge. Le transfert prendra effet \u00E0 partir du 12 mars 2024."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "Boulevard Patience et Beaujonc 3 \u00E0 4000 Li\u00E8ge",
        "city": "Li\u00E8ge",
        "region": "waals_gewest",
        "street": "Boulevard Patience et Beaujonc",
        "country": "BE",
        "postcode": "4000",
        "box_number": null,
        "street_number": "3",
        "locality_suffix": null
      },
      "old_address": {
        "raw": "Rue d\u00E8l Rodje Cinse, 98 \u00E0 4102 Seraing",
        "city": "Seraing",
        "region": "waals_gewest",
        "street": "Rue d\u00E8l Rodje Cinse",
        "country": "BE",
        "postcode": "4102",
        "box_number": null,
        "street_number": "98",
        "locality_suffix": null
      },
      "effective_date": "2024-03-12",
      "evidence_quote": "Le conseil d\u0027administration d\u00E9cide de transf\u00E9rer le si\u00E8ge de la soci\u00E9t\u00E9 de la Rue d\u00E8l Rodge Cinse 98 \u00E0 4102 Seraing vers le Boulevard Patience et Beaujonc 3 \u00E0 4000 Li\u00E8ge.",
      "region_changed": false,
      "is_statute_change": true,
      "nationality_change": false,
      "old_address_source": "header_volledig_adres",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "future",
      "statutaire_vs_werkelijke": null,
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": null,
    "filing_date": "2024-02-29",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "conseil_d_administration",
    "date": "2024-02-29",
    "unanimous": null
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "Amyl Therapeutics",
    "legal_form": "SRL"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0848.685.167",
    "org_name": "SRL Financial Way",
    "person_name": null,
    "org_rep_person_name": "Christophe MATHIEU",
    "person_role_at_subject": null
  },
  "co_filed_documents": []
}

{
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-02-12",
    "filing_date": "2024-02-08",
    "act_kind_objet": "DIVERS, CAPITAL, ACTIONS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "date": "2024-02-08",
    "unanimous": null
  },
  "agm_change": null,
  "detected_kind": "agm_rescheduling",
  "other_address": null,
  "mandate_renewal": null,
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  },
  "accounts_deposit": null,
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations, le rapport de l\u2019organe d\u2019administration et le rapport du commissaire",
    "la coordination des statuts"
  ],
  "fiscal_year_change": null,
  "liquidation_closure": null,
  "officer_designation": null,
  "special_procuration": null,
  "is_volet_a_only_stub": false,
  "vakbekwaamheid_change": null,
  "should_reroute_to_category": null,
  "single_shareholder_declaration": null
}

{
  "stage": null,
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-02-12",
    "filing_date": "2024-02-08",
    "act_kind_objet": "DIVERS, CAPITAL, ACTIONS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-02-08",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": {
    "summary": "The President dispenses himself from giving a full reading of the reports on the issuance of subscription rights, which were established by the administrative body and PwC.",
    "articles": [
      "5:102",
      "5:121",
      "5:122"
    ]
  },
  "restructuring": {
    "parties": [
      {
        "kbo": "0758.775.372",
        "name": "Amyl Therapeutics",
        "role": "contributor",
        "address": "Rue d\u00E8l Rodje Cinse 98, 4102 Seraing",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": null,
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "Amyl Therapeutics",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Geoffrey GAUTHY",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale Extraordinaire des actionnaires de la soci\u00E9t\u00E9 Amyl Therapeutics a d\u00E9cid\u00E9 d\u0027\u00E9mettre des droits de souscription anti-dilutifs nominatifs au prix de 0,01 \u20AC par droit. Ces droits donneront le droit de souscrire \u00E0 un nombre d\u0027actions de classe A2 d\u00E9termin\u00E9 par une formule dans le rapport de l\u0027organe d\u0027administration. L\u0027\u00E9mission est soumise \u00E0 la condition suspensive de l\u0027exercice du droit de souscription.",
  "co_filed_documents": [
    "exp\u00E9dition de l\u0027assembl\u00E9e comprenant les procurations, le rapport de l\u0027organe d\u0027administration et le rapport du commissaire",
    "la coordination des statuts"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}

{
  "events": [
    {
      "kind": "warrant_issuance",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-02-12",
    "filing_date": "2024-02-08",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-02-08",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "PwC",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "ADORANTE M\u00E9lanie"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "Amyl Therapeutics",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations, le rapport de l\u2019organe d\u2019administration et le rapport du commissaire",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 2000000,
      "currency": "EUR",
      "after_eur": null,
      "delta_eur": 2000000,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-09-08",
      "evidence_quote": "\u00E0 lib\u00E9rer imm\u00E9diatement \u00E0 concurrence de la totalit\u00E9 par un apport en num\u00E9raire de deux millions d\u2019euros (2.000.000,00 \u20AC) par Monsieur Evren Ucok.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": 2000000.0,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "Evren Ucok",
          "share_class": "A2",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 574713,
          "contribution_amount_eur": 2000000.0
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "A2",
        "n_new_shares": 574713,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 3.48
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 2000000.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "create"
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-09-12",
    "filing_date": "2023-09-08",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2023-09-08",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations, le rapport de l\u2019organe d\u2019administration, le rapport d\u2019un r\u00E9viseur et l\u2019attestation bancaire",
    "la coordination des statuts"
  ],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "person",
      "name": "Evren Ucok",
      "role": "aandeelhouder",
      "n_shares": 574713,
      "share_class": "A2"
    }
  ],
  "share_classes_after": [
    {
      "n_shares": 450000,
      "class_name": "Ordinaires",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 1555734,
      "class_name": "A1",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 1594830,
      "class_name": "A2",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 332669,
      "class_name": "NV",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    }
  ]
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 1500000.0,
      "currency": "EUR",
      "after_eur": null,
      "delta_eur": 1500000.0,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-04-04",
      "evidence_quote": "lib\u00E9rer imm\u00E9diatement \u00E0 concurrence de la totalit\u00E9 des apports en num\u00E9raire totaux d\u2019un million cinq cent mille euros (1.500.000,00 \u20AC)",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "share_emission",
      "after_eur": 1500000.0,
      "delta_eur": 1500000.0,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "A2",
        "n_new_shares": 431035,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 3.48
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 1500000.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "create"
    }
  ],
  "notary": {
    "name": "Jean-Michel GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2023-04-12",
    "filing_date": "2023-04-07",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "conseil_d_administration",
    "act_date": "2023-04-04",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": "2023-04-04"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u0027acte comprenant 2 procurations, 2 rapports du CA, 2 rapports du commissaire et l\u0027attestation bancaire",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 450000,
      "class_name": "Ordinaires",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 1555734,
      "class_name": "A1",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 1020117,
      "class_name": "A2",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 332669,
      "class_name": "NV",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    }
  ]
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "M\u00E9lanie Adorante",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SRL PwC Reviseurs d\u0027Entreprises",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale nomme la SRL PwC Reviseurs d\u0027Entreprises, ayant son si\u00E8ge social \u00E0 1831 Diegem, Culliganlaan 5, comme commissaire pour un terme de trois ans. Cette soci\u00E9t\u00E9 d\u00E9signe Madame M\u00E9lanie Adorante, r\u00E9viseur d\u0027entreprises, pour la repr\u00E9senter et la charge de l\u0027exercice de ce mandat au nom"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "M\u00E9lanie Adorante",
        "address": null,
        "birth_date": null,
        "profession": "r\u00E9viseur d\u0027entreprises",
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "SRL PwC Reviseurs d\u0027Entreprises",
        "address": "Culliganlaan 5, 1831 Diegem",
        "country": "BE",
        "legal_form": "SRL"
      },
      "statutory": "statutair",
      "compensated": true,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale nomme la SRL PwC Reviseurs d\u0027Entreprises, ayant son si\u00E8ge social \u00E0 1831 Diegem, Culliganlaan 5, comme commissaire pour un terme de trois ans.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "3"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "H\u00E9l\u00E8ne SABATEL",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2022-12-07",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale prend acte du remplacement, de Madame Amel TOUNSI par Madame H\u00E9l\u00E8ne SABATEL en qualit\u00E9 de repr\u00E9sentant permanent de la S.R.L. NOSHAQ PARTNERS, Administrateur, \u00E0 dater du 07 d\u00E9cembre 2022.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": "H\u00E9l\u00E8ne SABATEL",
      "rep_rotation_old_rep": "Amel TOUNSI",
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "M\u00E9lanie Adorante",
        "address": null,
        "birth_date": null,
        "profession": "r\u00E9viseur d\u0027entreprises",
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "SRL PwC Reviseurs d\u0027Entreprises",
        "address": "Culliganlaan 5, 1831 Diegem",
        "country": "BE",
        "legal_form": "SRL"
      },
      "statutory": "statutair",
      "compensated": true,
      "effective_date": null,
      "evidence_quote": "Cette soci\u00E9t\u00E9 d\u00E9signe Madame M\u00E9lanie Adorante, r\u00E9viseur d\u0027entreprises, pour la repr\u00E9senter et la charge de l\u0027exercice de ce mandat au nom et pour le compte de la SRL.",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "H\u00E9l\u00E8ne SABATEL",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2022-12-07",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale prend acte du remplacement, de Madame Amel TOUNSI par Madame H\u00E9l\u00E8ne SABATEL en qualit\u00E9 de repr\u00E9sentant permanent de la S.R.L. NOSHAQ PARTNERS, Administrateur, \u00E0 dater du 07 d\u00E9cembre 2022.",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": "H\u00E9l\u00E8ne SABATEL",
      "rep_rotation_old_rep": "Amel TOUNSI",
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "substantive_delegation",
      "role": "mandataire_special",
      "person": {
        "rrn": null,
        "name": "Christophe MATHIEU",
        "address": null,
        "birth_date": null,
        "profession": "administrateur",
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": "0848.685.167",
        "name": "SRL Fiduciaire de Wallonie",
        "address": "Esplanade du Val Saint Lambert \u00E0 4100 Seraing",
        "country": "BE",
        "legal_form": "SRL"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9signe comme mandataire sp\u00E9cial la SRL Fiduciaire de Wallonie, repr\u00E9sent\u00E9e par Monsieur Christophe MATHIEU, administrateur, ayant son si\u00E8ge social Esplanade du Val Saint Lambert \u00E0 4100 Seraing et inscrite aupr\u00E8s de la BCE sous le n\u00B0 0848.685.167, avec pouvoir de subd\u00E9l\u00E9gation, ",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Liege",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": null,
    "filing_date": "2023-03-23",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2022-12-07",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Financial Way SRL",
    "person_name": "Christophe MATHIEU",
    "org_rep_person_name": "Christophe MATHIEU",
    "person_role_at_subject": "Administrateur"
  },
  "co_filed_documents": [
    "Annexes du Moniteur belge"
  ],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "zetel_initial_set",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "All\u00E9e de la Cense-Rouge 98 : 4031 Li\u00E8ge",
        "city": "Li\u00E8ge",
        "region": "waals_gewest",
        "street": "All\u00E9e de la Cense-Rouge",
        "country": "BE",
        "postcode": "4031",
        "box_number": null,
        "street_number": "98",
        "locality_suffix": null
      },
      "old_address": null,
      "effective_date": null,
      "evidence_quote": "",
      "region_changed": false,
      "is_statute_change": false,
      "nationality_change": false,
      "old_address_source": "inferred",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "absolute",
      "statutaire_vs_werkelijke": null,
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    },
    {
      "kind": "zetel_transfer_cross_border_in",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "4102 Seraing, rue Del Rodje Cinse, 98",
        "city": "Seraing",
        "region": "waals_gewest",
        "street": "rue Del Rodje Cinse",
        "country": "BE",
        "postcode": "4102",
        "box_number": null,
        "street_number": "98",
        "locality_suffix": null
      },
      "old_address": {
        "raw": null,
        "city": "Li\u00E8ge",
        "region": "waals_gewest",
        "street": null,
        "country": "BE",
        "postcode": "4031",
        "box_number": null,
        "street_number": null,
        "locality_suffix": null
      },
      "effective_date": null,
      "evidence_quote": "",
      "region_changed": false,
      "is_statute_change": true,
      "nationality_change": false,
      "old_address_source": "act_body",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "absolute",
      "statutaire_vs_werkelijke": "statutaire",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": "Jean-Michel GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY \u0026 JACQUES \u2013 Notaires Associ\u00E9s",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2022-06-30",
    "filing_date": "2022-06-28",
    "act_kind_objet": "SIEGE SOCIAL, CAPITAL, ACTIONS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "date": "2022-06-27",
    "unanimous": null
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Jean-Michel GAUTHY",
    "org_rep_person_name": null,
    "person_role_at_subject": "notaire associ\u00E9"
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant 10 procurations et le rapport sp\u00E9cial de l\u2019organe d\u2019administration",
    "la coordination des statuts"
  ]
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Seraing",
        "region": null,
        "street": "rue Del Rodje Cinse",
        "country": "BE",
        "postcode": "4102",
        "box_number": null,
        "street_number": "98"
      },
      "old_address": {
        "city": "Li\u00E8ge",
        "region": null,
        "street": "All\u00E9e de la Cense-Rouge",
        "country": "BE",
        "postcode": "4031",
        "box_number": null,
        "street_number": "98"
      },
      "effective_date": "2022-06-27",
      "evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9clare que l\u2019adresse du si\u00E8ge est situ\u00E9e \u00E0 4102 Seraing, rue Del Rodje Cinse, 98."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "NV",
        "n_new_shares": 332669,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Jean-Michel GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY \u0026 JACQUES \u2013 Notaires Associ\u00E9s",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2022-06-30",
    "filing_date": "2022-06-28",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2022-06-27",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "Amyl Therapeutics",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant 10 procurations et le rapport sp\u00E9cial de l\u2019organe d\u2019administration",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 450000,
      "class_name": "Actions Ordinaires",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 1555734,
      "class_name": "Classe A1",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 589082,
      "class_name": "Classe A2",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 332669,
      "class_name": "Classe NV",
      "capital_share_eur": null,
      "voting_rights_per_share": 0.0
    }
  ]
}

{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "TOUNSI Amel",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-03-29",
      "evidence_quote": "L\u0027assembl\u00E9e constate qu\u0027a d\u00E8s lors \u00E9t\u00E9 nomm\u00E9e comme administrateur de la Soci\u00E9t\u00E9 avec effet au 29 mars 2021 : la soci\u00E9t\u00E9 coop\u00E9rative \u00E0 responsabilit\u00E9 limit\u00E9e NOSHAQ PARTNERS, ayant son si\u00E8ge \u00E0 4000 Li\u00E8ge, Rue Lambert-Lombard 3, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent, Madame TOUNSI Amel, domicili"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Pierre Vandepapeli\u00E8re",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0568548672",
        "name": "Vaccibio Consulting",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-03-29",
      "evidence_quote": "Le conseil d\u0027administration a d\u00E9cid\u00E9 de nommer Vaccibio Consulting, une soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e, ayant son si\u00E8ge \u00E0 5021 Namur (Boninne), Rue du Long-Sart 38, inscrite au registre des personnes morales sous le num\u00E9ro 0568.548.672, repr\u00E9sent\u00E9e de fa\u00E7on permanente par M. Pierre Vandepapeli\u00E8re,"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Florent Gros",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0734792024",
        "name": "Swissvention Partners GmbH",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-03-29",
      "evidence_quote": "Le conseil d\u0027administration a d\u00E9cid\u00E9 de nommer Swissvention Partners GmbH, une soci\u00E9t\u00E9 de droit suisse, ayant son si\u00E8ge \u00E0 4055 Basel, Strassburgerallee 107, inscrite au registre des personnes morales sous le num\u00E9ro 0734.792.024, repr\u00E9sent\u00E9e de fa\u00E7on permanente par M. Florent Gros en qualit\u00E9 de pr\u00E9si"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "BUCKFIRE Kenneth",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-04-13",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de nommer les administrateurs suivants, et ce \u00E0 partir de ce jour: - Monsieur BUCKFIRE Kenneth, pr\u00E9nomm\u00E9 ci-dessus;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "CALENDA Val\u00E9rie",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-04-13",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de nommer les administrateurs suivants, et ce \u00E0 partir de ce jour: - Madame CALENDA Val\u00E9rie, domicili\u00E9e \u00E0 Rue du Puits D\u0027Ouillon 5, 69660 Collonges-Au-Mont-D\u0027Or (France);"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "TOUNSI Amel",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-04-13",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de nommer les administrateurs suivants, et ce \u00E0 partir de ce jour: - Madame TOUNSI Amel, domicili\u00E9e \u00E0 1090 Jette, Place Jean Gabin 1 A001."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "GROS Florent",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SWISSVENTION PARTNERS GMBH",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-04-13",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de nommer les administrateurs suivants, et ce \u00E0 partir de ce jour: ... [implied by context of appointment resolution and subsequent remuneration decision for the independent director mandate of the company]"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2021-03-29",
    "legal_form_change": false
  },
  "bedrijfsrevisor": {
    "quote": "Le rapport du r\u00E9viseur d\u0027entreprises en date du 25 mars 2021, \u00E9tabli par la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e Moore Audit, ayant son si\u00E8ge \u00E0 Schali\u00EBnstraat 3, 2000 Anvers, repr\u00E9sent\u00E9e par M. Stijn Van Hout, inscrite au registre des personnes morales sous le num\u00E9ro 0453.925.059",
    "firm_kbo": "0453.925.059",
    "firm_name": "Moore Audit",
    "ibr_number": null,
    "individual_name": "Stijn Van Hout"
  },
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "AMYL THERAPEUTICS",
    "legal_form": "SRL"
  },
  "signature_regime": "joint_by_class",
  "special_mandates": [
    {
      "quote": "L\u0027assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 Ma\u00EEtre Louisa Vandepitte, Ma\u00EEtre Maxine Daems ou tout autre avocat ou collaborateur du cabinet NautaDutilh, situ\u00E9 \u00E0 1000 Bruxelles, Chauss\u00E9e de La Hulpe 120, chacun agissant s\u00E9par\u00E9ment, ainsi qu\u0027\u00E0 leurs employ\u00E9s, pr\u00E9pos\u00E9s et mandataires, avec droit de substitution, afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u0027entreprise en vue d\u0027assurer l\u0027inscription/la modification des donn\u00E9es dans la Banque Carrefour des Entreprises et, le cas \u00E9ch\u00E9ant, aupr\u00E8s de l\u0027Administration de la Taxe sur la Valeur Ajout\u00E9e.",
      "holder_kbo": null,
      "holder_name": "Ma\u00EEtre Louisa Vandepitte",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    },
    {
      "quote": "L\u0027assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 Ma\u00EEtre Louisa Vandepitte, Ma\u00EEtre Maxine Daems ou tout autre avocat ou collaborateur du cabinet NautaDutilh, situ\u00E9 \u00E0 1000 Bruxelles, Chauss\u00E9e de La Hulpe 120, chacun agissant s\u00E9par\u00E9ment, ainsi qu\u0027\u00E0 leurs employ\u00E9s, pr\u00E9pos\u00E9s et mandataires, avec droit de substitution, afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u0027entreprise en vue d\u0027assurer l\u0027inscription/la modification des donn\u00E9es dans la Banque Carrefour des Entreprises et, le cas \u00E9ch\u00E9ant, aupr\u00E8s de l\u0027Administration de la Taxe sur la Valeur Ajout\u00E9e.",
      "holder_kbo": null,
      "holder_name": "Ma\u00EEtre Maxine Daems",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    },
    {
      "quote": "L\u0027assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 Ma\u00EEtre Louisa Vandepitte, Ma\u00EEtre Maxine Daems ou tout autre avocat ou collaborateur du cabinet NautaDutilh, situ\u00E9 \u00E0 1000 Bruxelles, Chauss\u00E9e de La Hulpe 120, chacun agissant s\u00E9par\u00E9ment, ainsi qu\u0027\u00E0 leurs employ\u00E9s, pr\u00E9pos\u00E9s et mandataires, avec droit de substitution, afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u0027entreprise en vue d\u0027assurer l\u0027inscription/la modification des donn\u00E9es dans la Banque Carrefour des Entreprises et, le cas \u00E9ch\u00E9ant, aupr\u00E8s de l\u0027Administration de la Taxe sur la Valeur Ajout\u00E9e.",
      "holder_kbo": null,
      "holder_name": "NautaDutilh",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "kind": "oprichting",
  "seat": "Quai Banning 6, 4000 Li\u00E8ge",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": {
        "kbo": null,
        "name": "VACCIBIO CONSULTING"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "nominatives",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": "VACCIBIO CONSULTING",
      "contribution_type": "cash",
      "amount_paid_in_eur": 1260,
      "holder_person_name": null,
      "is_subscriber_only": false,
      "n_shares_subscribed": 315000,
      "amount_subscribed_eur": 1260,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": null,
        "name": "SWISSVENTION PARTNERS GMBH"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "nominatives",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": "SWISSVENTION PARTNERS GMBH",
      "contribution_type": "cash",
      "amount_paid_in_eur": 540,
      "holder_person_name": null,
      "is_subscriber_only": false,
      "n_shares_subscribed": 135000,
      "amount_subscribed_eur": 540,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 2000,
  "subject_company": {
    "kbo": "0758.775.372",
    "name_full": "Amyl Therapeutics",
    "legal_form": "SRL"
  },
  "initial_directors": [],
  "incorporation_date": "2020-11-25",
  "post_incorporation_mandates": []
}